Cargando…
Prediction of cancer treatment response from histopathology images through imputed transcriptomics
Advances in artificial intelligence have paved the way for leveraging hematoxylin and eosin (H&E)-stained tumor slides for precision oncology. We present ENLIGHT-DeepPT, an approach for predicting response to multiple targeted and immunotherapies from H&E-slides. In difference from existing...
Autores principales: | Hoang, Danh-Tai, Dinstag, Gal, Hermida, Leandro C., Ben-Zvi, Doreen S., Elis, Efrat, Caley, Katherine, Sammut, Stephen-John, Sinha, Sanju, Sinha, Neelam, Dampier, Christopher H., Stossel, Chani, Patil, Tejas, Rajan, Arun, Lassoued, Wiem, Strauss, Julius, Bailey, Shania, Allen, Clint, Redman, Jason, Beker, Tuvik, Jiang, Peng, Golan, Talia, Wilkinson, Scott, Sowalsky, Adam G., Pine, Sharon R., Caldas, Carlos, Gulley, James L., Aldape, Kenneth, Aharonov, Ranit, Stone, Eric A., Ruppin, Eytan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543028/ https://www.ncbi.nlm.nih.gov/pubmed/37790315 http://dx.doi.org/10.21203/rs.3.rs-3193270/v1 |
Ejemplares similares
-
Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab
por: Berger, Raanan, et al.
Publicado: (2022) -
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome
por: Dinstag, Gal, et al.
Publicado: (2023) -
Big data in basic and translational cancer research
por: Jiang, Peng, et al.
Publicado: (2022) -
In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression
por: Sinha, Sanju, et al.
Publicado: (2020) -
Immune Determinants of the Association between Tumor Mutational Burden and Immunotherapy Response across Cancer Types
por: Sinha, Neelam, et al.
Publicado: (2022)